Print

Micromet Appoints Joseph Lobacki Senior Vice President and Chief Commercial Officer  
12/5/2011 6:23:09 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--Micromet, Inc. (NASDAQ: MITI) today announced the appointment of Joseph Lobacki as Senior Vice President and Chief Commercial Officer.

Mr. Lobacki brings to Micromet over 25 years of commercial experience in the biopharmaceutical industry. From 2003 to 2011, Mr. Lobacki served as Senior Vice President and General Manager, Transplant and Oncology at Genzyme and as a member of the company’s senior management team. In this role, he was responsible for directing overall strategy for the company’s global hematology, oncology, and organ transplant business. Under his leadership Genzyme’s transplant/oncology franchise consistently produced double digit percent revenue growth through expansion of product market share, geographical growth, clinical market development and business acquisitions.